Clinical Trials Logo

Clinical Trial Summary

This study will check how and to whom Vyvanse is prescribed in Australia by retrospectively analyzing a prescription database with additional information provided by a physician survey.

Clinical Trial Description

This is a drug utilization study (DUS) using cross-sectional database analysis of participants who are prescribed lisdexamfetamine dimesylate for treatment of BED. The study will combine data from two sources of patient-level drug utilization data for lisdexamfetamine dimesylate: - NostraData database: Longitudinal participant level prescription dispensing database - Physician survey: De-identified participant data provided by representative psychiatrists and other physicians expected to treat participants with BED in Australia. In the NostraData database, actual drug dispensing data are collected, which allows for the generation of information on actual drug usage. However, these data do not contain certain participant variables, such as age and indication, needed to monitor potential off-label use. Therefore, these data must be supplemented with another data source. The physician survey will provide the data not included in the NostraData database. The DUS will enroll approximately 150 participants. This DUS will be conducted in Australia. The overall time for data collection in the study will be approximately 36 months after the launch date of lisdexamfetamine dimesylate. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT04866043
Study type Observational
Source Takeda
Status Active, not recruiting
Start date June 1, 2019
Completion date October 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04572087 - Ameliorating Cognitive Control in Binge Eating Disorder N/A
Enrolling by invitation NCT03063606 - Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment Phase 2/Phase 3
Recruiting NCT03678766 - CHARGE: Controlling Hunger and ReGulating Eating N/A
Enrolling by invitation NCT04174703 - Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing N/A
Terminated NCT03279731 - Binge Eating Liraglutide Intervention Phase 3
Recruiting NCT04278755 - Binge Eating & Birth Control Phase 2
Completed NCT02419326 - Uniting Couples In the Treatment of Eating Disorders (UNITE) N/A
Completed NCT00210808 - A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity Phase 2/Phase 3
Recruiting NCT04115852 - Interoceptive Nutritional Processing in Healthy Participants and Patients With Binge-Eating-Disorder
Completed NCT03113669 - Project BITE: Binge Intervention Target Effectiveness N/A
Recruiting NCT04265131 - Emotion Regulation in Eating Disorders: How Can Art Therapy Contribute to Treatment Outcome? N/A
Completed NCT03712748 - Online Imaginal Exposure N/A
Recruiting NCT04076553 - Augmenting Cognitive Behavioral Therapy With Inhibitory Control Training N/A
Not yet recruiting NCT04101032 - eBEfree - an ICT Adaptation of BEfree N/A
Active, not recruiting NCT03317379 - Evaluation of the Communities of Healing Mentorship/Support Group Program: Assessment of Preliminary Efficacy N/A
Not yet recruiting NCT04125589 - Decision Making, Daily Experiences, and Brain Activity in Young Adult Women N/A
Completed NCT02783872 - Emotion Regulation and Binge Eating in Youth With Obesity
Not yet recruiting NCT04454684 - A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders Phase 2
Active, not recruiting NCT02571387 - MindOb: A 12-month Computerized Mindfulness-based Intervention for Obese Individuals N/A
Completed NCT00327834 - Atomoxetine in the Treatment of Binge Eating Disorder Phase 4